CSF evidence of pericyte damage in Alzheimer's disease is associated with markers of blood-brain barrier dysfunction and disease pathology.

Alzheimers Res Ther · 2019 · PMC6745071 · PMID 31521199

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Mean CSF albumin level was higher in AD than in controls, but the difference did not reach statistical significance (150.1 μg/mL ± 8.6 in AD v 135.6 μg/mL ± 6.9 in controls) (Fig. 1 b).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.